Update to the Quarterly Index Review
Review Announcement Q1/2015 published on 13 March 2015

Frankfurt (17 March 2015) – Update to the review results of Market Vectors US Listed Pharmaceutical 25 Index (MVPPH).

New weighting cap factors for MVPPH due to the acquisition of Allergan by Actavis. Allergan has been removed from the index after the close of business on 16 March 2015 and has been replaced by Amerisourcebergen effective today.

A new review file is available.